TrialBreast cancer research and treatment2024

A randomised trial comparing 6-monthly adjuvant zoledronate with a single one-time dose in patients with early breast cancer.

Arif Ali Awan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.